Lilly Eli Co stock is traded at $1,391.71, with a volume of 1,162,337. It is down -1.68% in the last 24 hours and up +10.71% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,415.55
Open:
$1,407.93
24h Volume:
1,162,337
Relative Volume:
0.37
Market Cap:
$1.24T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
50.10
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
-3.17%
1M Performance:
+10.71%
6M Performance:
+40.85%
1Y Performance:
+35.11%
1-Day Range:
$1,384.59$1,423.11
1-Week Range:
$1,384.59$1,475.25
52-Week Range:
$850.51$1,475.25
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS